Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in Pseudomonas aeruginosa-Induced Keratitis

Our previous work has shown that topical thymosin beta 4 (Tβ4) as an adjunct to ciprofloxacin treatment reduces inflammatory mediators and inflammatory cell infiltrates (neutrophils/PMN and macrophages/MΦ) while enhancing bacterial killing and wound healing pathway activation in an experimental mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuxin, Carion, Thomas W., Ebrahim, Abdul Shukkur, Sosne, Gabriel, Berger, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537948/
https://www.ncbi.nlm.nih.gov/pubmed/34681676
http://dx.doi.org/10.3390/ijms222011016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537948/
https://www.ncbi.nlm.nih.gov/pubmed/34681676
http://dx.doi.org/10.3390/ijms222011016

Ejemplares similares